Search Result "Naratriptan efficacy"
Preparation and Optimization of Fast Dissolving Film of Naratriptan Hydrochloride
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 11 Issue: 2 Year: 2017 Page: 124-131
Author(s): Koradia D. Krishna,Sidhdhapara T. Pradip,Sheth R. Navin
Individual Triptan Selection in Migraine Attack Therapy
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 4 Issue: 1 Year: 2009 Page: 70-81
Author(s): Robert Belvis, Javier Pagonabarraga, Jaime Kulisevsky
Migraine Attack Treatment : A Tailor-made Suit, Not One Size Fits All
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 9 Issue: 1 Year: 2014 Page: 26-40
Author(s): Robert Belvis, Natalia Mas, Azahara Aceituno
Migraine: Pathophysiology, Pharmacology, Treatment and Future Trends
Journal: Current Vascular Pharmacology
Volume: 1 Issue: 1 Year: 2003 Page: 71-84
Author(s):
microRNAs to Monitor Pain-migraine and Drug Treatment
Journal: MicroRNA
Volume: 6 Issue: 3 Year: 2017 Page: 152-156
Author(s): Luca Gallelli,Erika Cione,Maria Cristina Caroleo,Marco Carotenuto,Pasqualina Lagana,Antonio Siniscalchi,Vincenzo Guidetti
Metoclopramide as an Analgesic in Severe Migraine Attacks: An Open, Single-blind, Parallel Control Study
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 6 Issue: 2 Year: 2011 Page: 141-145
Author(s): Gabriel Salazar, Marta Fragoso, Luis Vergez, Piera Sergio, Denisse Cuello
Formulation Approaches of Triptans for Management of Migraine
Journal: Current Drug Delivery
Volume: 13 Issue: 6 Year: 2016 Page: 882-898
Author(s): Abeer Ahmed Kassem
Clinical Pharmacology of Current and Future Drugs for the Acute Treatment of Migraine: A Review and An Update
Journal: Current Clinical Pharmacology
Volume: 7 Issue: 1 Year: 2012 Page: 66-72
Author(s): Peer Tfelt-Hansen
Disentangling the Intricacies of Migraine: A Review
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 5 Year: 2014 Page: 776-791
Author(s): Priti Girotra,Shailendra Kumar Singh,Deepika Saini
Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12 Issue: 4 Year: 2012 Page: 241-249
Author(s): Dimos D. Mitsikostas,Peer Tfelt-Hansen